Niosome encapsulation of curcumin: Characterization and cytotoxic effect on ovarian cancer cells

Journal of Nanomaterials

Volumn 2016, Issue , 2016, Pages

  Xu, Ying Qi ^a   Chen, Wen Rong ^b   Tsosie, Jonathan K ^c   Xie, Xi ^d   Li, Peng ^a   Wan, Jian Bo ^a   He, Cheng Wei ^a   Chen, Mei Wan ^a  

^a University of Macau   (Macao)

^b GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL STABILITY; DISEASES; DRUG PRODUCTS; NONIONIC SURFACTANTS;

CONTROLLED RELEASE; CYTOTOXIC ACTIVITIES; CYTOTOXIC EFFECTS; HIGH ENTRAPMENT EFFICIENCIES; OVARIAN CANCER CELLS; OVARIAN CANCERS; POOR STABILITY; RAPID DEGRADATION;

CYTOTOXICITY;

EID: 84982830500     PISSN: 16874110     EISSN: 16874129     Source Type: Journal    
DOI: 10.1155/2016/6365295     Document Type: Article

References (38)

1. O. Naksuriya, S. Okonogi, R. M. Schiffelers, and W. E. Hennink. Curcumin nanoformulations: a reviewof pharmaceutical properties, and preclinical studies, and clinical data related to cancer treatment. Biomaterials, vol. 35, no. 10, pp. 3365-3383, 2014
2. N. G. Vallianou, A. Evangelopoulos, N. Schizas, and C. Kazazis. Potential anticancer properties, and mechanisms of action of curcumin. Anticancer Research, vol. 35, no. 2, pp. 645-651, 2015
3. C. N. Sreekanth, S. V. Bava, E. Sreekumar, and R. J. Anto. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy inmousemodels of cervical cancer. Oncogene, vol. 30, no. 28, pp. 3139-3152, 2011
4. M. Heger, R. F. van Golen, M. Broekgaarden, and M. C. Michel. The molecular basis for the pharmacokinetics, and pharmacodynamics of curcumin, and its metabolites in relation to cancers. Pharmacological Reviews, vol. 66, no. 1, pp. 222-307, 2014
5. A. Shehzad, F. Wahid, and Y. S. Lee. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Archiv der Pharmazie, vol. 343, no. 9, pp. 489-499, 2010
6. N. M. Khalil, T. C. F. D. Nascimento, D. M. Casa, et al. Pharmacokinetics of curcumin-loaded PLGA, and PLGA-PEG blend nanoparticles after oral administration in rats. Colloids, and Surfaces B: Biointerfaces, vol. 101, pp. 353-360, 2013
7. P. Anand, A. B. Kunnumakkara, R. A.Newman, andB. B. Aggarwal. Bioavailability of curcumin: problems, and promises. Molecular Pharmaceutics, vol. 4, no. 6, pp. 807-818, 2007
8. S. Barui, S. Saha, G. Mondal, S. Haseena, and A. Chaudhuri. Simultaneous delivery of doxorubicin, and curcumin encapsulated in liposomes of pegylated RGDK-lipopeptide to tumor vasculature. Biomaterials, vol. 35, no. 5, pp. 1643-1656, 2014
9. X. Zhao, Q. Chen, W. Liu, et al. Codelivery of doxorubicin, and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer. International Journal of Nanomedicine, vol. 10, pp. 257-270, 2015
10. K. Nagahama, Y. Sano, and T. Kumano. Anticancer drug-based multifunctional nanogels through self-Assembly of dextrancurcumin conjugates toward cancer theranostics. Bioorganic & Medicinal Chemistry Letters, vol. 25, no. 12, pp. 2519-2522, 2015
11. S. P. Singh, M. Sharma, and P. K. Gupta. Cytotoxicity of curcumin silica nanoparticle complexes conjugated with hyaluronic acid on colon cancer cells. International Journal of Biological Macromolecules, vol. 74, pp. 162-170, 2015
12. A. Kumar, A. Ahuja, J. Ali, and S. Baboota. Curcumin loaded nano globules for solubility enhancement: preparation, characterization, and ex vivo release study. Journal of Nanoscience, and Nanotechnology, vol. 12, no. 11, pp. 8293-8302, 2012
13. X. Xie, A. M. Xu, S. Leal-Ortiz, Y. Cao, C. C. Garner, and N. A. Melosh. Nanostraw-electroporation system for highly efficient intracellular delivery, and transfection. ACS Nano, vol. 7, no. 5, pp. 4351-4358, 2013
14. X. Xie, A. M. Xu, M. R. Angle, N. Tayebi, P. Verma, and N. A. Melosh. Mechanical model of vertical nanowire cell penetration. Nano Letters, vol. 13, no. 12, pp. 6002-6008, 2013
15. M. Chen, Z. Zhong, W. Tan, S. Wang, and Y. Wang. Recent advances in nanoparticle formulation of oleanolic acid. Chinese Medicine, vol. 6, article 20, 2011
16. G. Puras, M. Mashal, J. Zárate, et al. A novel cationic niosome formulation for gene delivery to the retina. Journal of Controlled Release, vol. 174, no. 1, pp. 27-36, 2014
17. R. Rajera, K. Nagpal, S.K. Singh, andD. N. Mishra. Niosomes: a controlled, and novel drug delivery system. Biological, and Pharmaceutical Bulletin, vol. 34, no. 7, pp. 945-953, 2011
18. A. Azeem, M. K. Anwer, and S. Talegaonkar. Niosomes in sustained, and targeted drug delivery: some recent advances. Journal of Drug Targeting, vol. 17, no. 9, pp. 671-689, 2009
19. D. Cosco, D. Paolino, R. Muzzalupo, et al. Novel PEG-coated niosomes based on bola-surfactant as drug carriers for 5-fluorouracil. Biomedical Microdevices, vol. 11, no. 5, pp. 1115-1125, 2009
20. G. Abdelbary, and N. El-Gendy. Niosome-encapsulated gentamicin for ophthalmic controlled delivery. AAPS Pharm-SciTech, vol. 9, no. 3, pp. 740-747, 2008
21. N.Yuksel, Z. S. Bayindir, E. Aksakal, andA.T.Ozcelikay. In situ niosome forming maltodextrin proniosomes of candesartan cilexetil: in vitro, and in vivo evaluations. International Journal of Biological Macromolecules, vol. 82, pp. 453-463, 2016
22. M. Najlah, K. Hidayat, H. K. Omer, et al. A facile approach to manufacturing non-ionic surfactant nanodipsersions using proniosome technology, and high-pressure homogenization. Journal of Liposome Research, vol. 25, no. 1, pp. 32-37, 2015
23. Y.-Z. Zhao, C.-T. Lu, Y. Zhang, et al. Selection of high efficient transdermal lipid vesicle for curcumin skin delivery. International Journal of Pharmaceutics, vol. 454, no. 1, pp. 302-309, 2013
24. C. F. Chignell, P. Bilski, K. J. Reszka, A. G. Motten, R. H. Sik, and T. A. Dahl. Spectral, and photochemical properties of curcumin. Photochemistry, and Photobiology, vol. 59, no. 3, pp. 295-302, 1994
25. S. Wang, R. Chen, Z. Zhong, Z. Shi, M. Chen, and Y. Wang. Epigallocatechin-3-gallate potentiates the effect of curcumin in inducing growth inhibition, and apoptosis of resistant breast cancer cells. American Journal of Chinese Medicine, vol. 42, no. 5, pp. 1279-1300, 2014
26. J.-L. Gao, T.-C. He, Y.-B. Li, and Y.-T. Wang. A traditional Chinesemedicine formulation consisting of RhizomaCorydalis, and Rhizoma Curcumae exerts synergistic anti-Tumor activity. Oncology Reports, vol. 22, no. 5, pp. 1077-1083, 2009
27. X.-Y. Ke, V.W. Lin Ng, S.-J.Gao, Y.W. Tong, J. L. Hedrick, and Y. Y. Yang. Co-delivery of thioridazine, and doxorubicin using polymeric micelles for targeting both cancer cells, and cancer stem cells. Biomaterials, vol. 35, no. 3, pp. 1096-1108, 2014
28. L. Ouyang, Z. Shi, S. Zhao, et al. Programmed cell death pathways in cancer: a review of apoptosis, autophagy, and programmed necrosis. Cell Proliferation, vol. 45, no. 6, pp. 487-498, 2012
29. S. Wang, R. Chen, J. Morott, M. A. Repka, Y. Wang, and M. Chen. MPEG-b-PCL/TPGS mixed micelles for delivery of resveratrol in overcoming resistant breast cancer. Expert Opinion on Drug Delivery, vol. 12, no. 3, pp. 361-373, 2015
30. A. H. I. Garces, M. S. F. Dias, E. Paulino, C. G. M. Ferreira, and A. C. De Melo. Treatment of ovarian cancer beyond chemotherapy: arewe hitting the target? Cancer Chemotherapy, and Pharmacology, vol. 75, no. 2, pp. 221-234, 2015
31. S. Carpi, S. Fogli, A. Giannetti, et al. Theranostic properties of a survivin-directedmolecular beacon in human melanoma cells. PLoS ONE, vol. 9, no. 12, article e114588, 2014
32. S. Mondal, S. Ghosh, and S. P. Moulik. Stability of curcumin in different solvent, and solution media: UV-visible, and steadystate fluorescence spectral study. Journal of Photochemistry, and Photobiology B: Biology, vol. 158, pp. 212-218, 2016
33. A. Karewicz, D. Bielska, B. Gzyl-Malcher, M. Kepczynski, R. Lach, and M. Nowakowska. Interaction of curcumin with lipid monolayers, and liposomal bilayers. Colloids, and Surfaces B: Biointerfaces, vol. 88, no. 1, pp. 231-239, 2011
34. S. Ghanbarzadeh, A. Khorrami, Z. Pourmoazzen, and S. Arami. Plasma stable, pH-sensitive non-ionic surfactant vesicles simultaneously enhance antiproliferative effect, and selectivity of Sirolimus. Pharmaceutical Development, and Technology, vol. 20, no. 3, pp. 279-287, 2015
35. Y.-L. Lin, Y.-K. Liu, N.-M. Tsai, et al. A Lipo-PEG-PEI complex for encapsulating curcumin that enhances its antitumor effects on curcumin-sensitive, and curcumin-resistance cells. Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 8, no. 3, pp. 318-327, 2012
36. C. Li, Y. Zhang, T. T. Su, L. Feng, Y. Long, and Z. Chen. Silicacoated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcumin. International Journal of Nanomedicine, vol. 7, pp. 5995-6002, 2012
37. F. Re, I. Cambianica, C. Zona, et al. Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake, and drug transport across a blood-brain barrier model. Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 7, no. 5, pp. 551-559, 2011
38. A. N. Lazar, S.Mourtas, I. Youssef, et al. Curcumin-conjugated nanoliposomes with high affinity for Aδ deposits: possible applications to Alzheimer disease. Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 9, no. 5, pp. 712-721, 2013